National Health Partners, Inc. (NHPR)

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. National Health Partners, Inc primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.
The United States is the only industrialized nation that does not have a HEALTH
CARE SYSTEM. The current way health care is managed in the U.S. is more than
dysfunctional. Some consider it unethical and highly immoral. Unlike health care in
other developed countries where a citizen's right to health care and the health of
the nation's workforce is primary, in the U.S. pro?ts, of hospitals, insurance
companies, medical equipment manufacturers appears to be the ?rst priority.
Today, in America, patients are often considered consumers from whom to extract
pro?ts, especially when they are sick or injured. Instead of a system, a thinly
regulated market drives health care decisions, oftentimes to the detriment of
ordinary citizens.

National Health Partners, Inc. (NHPR), a leading provider of unique discount healthcare membership programs, announced that it has entered into agreement with a major Hispanic marketing group for the sale of its CARExpress programs. The company also sees growth in new sales of memberships of more than 300% thru the remainder of the year.

Under the new agreement, this national Hispanic marketing group will be promoting the company's CARExpress discount healthcare membership program to Hispanic communities located across the United States, with particular focus on cities and regions containing a large number of Hispanics. With the previously announced plans to increase monthly sales by 75% with its newest and most successful marketing partner, the company now expects sales of new members to grow more than 300% thru the remainder of the year.

For more information about National Health Partners, Inc. please visit their website: www.nationalhealthpartners.com.

******************************************************************

GenVec, Inc. (Nasdaq:GNVC) will report financial results for the second quarter of 2011 on Tuesday, August 9, 2011, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's second quarter financial results and business outlook. To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 84527868. An audio replay of the conference call will be available starting at 1:00 p.m. EDT on August 9, 2011 through August 16, 2011. To listen to the audio replay, dial 855-859-2056 or 404-537-3406 and use Conference Replay ID: 84527868.

GenVec, Inc., a biopharmaceutical company, engages in developing novel gene-based therapeutic drugs and vaccines. The company uses proprietary drug discovery and development technologies to support a portfolio of product programs that address the prevention and treatment of various diseases.

******************************************************************

Cleantech Transit Inc (CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).

Geothermal energy is thermal energy generated and stored in the Earth. Thermal energy is energy that determines the temperature of matter. Earth's geothermal energy originates from the original formation of the planet, from radioactive decay of minerals and from volcanic activity. The geothermal gradient, which is the difference in temperature between the core of the planet and its surface, drives a continuous conduction of thermal energy in the form of heat from the core to the surface.

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

For more information about CLNO, visit www.cleantechtransitinc.com

******************************************************************

Commtouch (NASDAQ:CTCH) announced its second quarter 2011 results, ended June 30, 2011. Revenues for the second quarter of 2011 increased by 39% to $5.7 million compared to $4.1 million in the second quarter of 2010. Net income in accordance with US Generally Accepted Accounting Principles (US GAAP) for the second quarter of 2011 increased by 60% to $1.4 million, as compared with $0.9 million in the second quarter of 2010.

Commtouch Software Ltd., together with its subsidiaries, develops and provides messaging, antivirus, and Web security solutions primarily to original equipment manufacturer partners and enterprises.

******************************************************************

Depomed, Inc. (NasdaqEPO) reported financial results for the second quarter ended June 30, 2011. Total revenues for the quarter were $21.2 million compared to $24.4 million for the second quarter of 2010. Net loss for the quarter was $5.7 million, or $0.11 per share, compared to net income of $4.1 million, or $0.08 per share for the second quarter of 2010. Net income for the second quarter of 2010 included the one-time recognition of a $10 million milestone payment from Abbott Products, Inc. related to the FDA's acceptance for review of the New Drug Application for GraliseTM (gabapentin). Cash, cash equivalents and marketable securities were $164.2 million as of June 30, 2011 compared to $76.9 million as of December 31, 2010.

Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States.



Sign Up For Free Stock Alerts At http://crwewallstreet.com/signup

******************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).